Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 104195 

webcast, please email 

IACCPublicInquiries@mail.nih.gov. 

Disability Accommodations: All IACC 

Full Committee Meetings provide 

Closed Captioning through the Zoom 

platform. Individuals whose full 

participation in the meeting will require 

special accommodations (e.g., sign 

language or interpreting services, etc.) 

must submit a request to the Contact 

Person listed on the notice at least seven 

(7) business days prior to the meeting. 

Such requests should include a detailed 

description of the accommodation 

needed and a way for the IACC to 

contact the requester if more 

information is needed to fill the request. 

Special requests should be made at least 

seven (7) business days prior to the 

meeting; last-minute requests may be 

made but may not be possible to 

accommodate. 

Meeting schedule subject to change. 

More Information 

Information about the IACC is 

available on the website: http://

www.iacc.hhs.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. In 

the interest of security, NIH has 

procedures at https://www.nih.gov/ 

about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal 

facility will be asked to show one form 

of identification (for example, a 

government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Dated: December 16, 2024. 

David W Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–30338 Filed 12–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and contract proposals, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Diet, Lipid 

Metabolism, and Cancer. 

Date: January 30, 2025. 

Time: 9:30 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W248, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer ,Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248 Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational Cancer Research. 

Date: February 12, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W248, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer ,Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248 Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; RNA 

Modifications Driving Oncogenesis 

(RNAMoDO; U01 Clinical Trial Not 

Allowed). 

Date: February 14, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W260, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Robert F. Gahl, Ph.D., 

Scientific Review Officer, Special Review 

Branch ,Division of Extramural Activities, 

National Cancer Institute, NIH, 9606 Medical 

Center Drive, Room 7W260 Rockville, 

Maryland 20850, 240–276–7869, robert.gahl@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Prevention Clinical Trials Network—Sites 

and Data Management. 

Date: February 14, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W108, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–12: 

NCI Clinical and Translational Cancer 

Research. 

Date: February 14, 2025. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W244, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Amr M. Ghaleb, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 240–276–6611, 

amr.ghaleb@nih.gov 

Name of Committee: National Cancer 

Institute Initial Review Group; Career 

Development Study Section (J). 

Date: February 19–20, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR 

Concept Award TEP. 

Date: February 21, 2025. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W608, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W608, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1
104196 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–8: NCI 

Clinical and Translational Cancer Research. 

Date: February 25, 2025. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W110, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Priya Srinivasan, Ph.D., 

Scientific Review Officer, Resource and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W110, Rockville, Maryland 20850, 

240–276–5619, priya.srinivasan@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–1: 

SBIR Contract Review Meeting. 

Date: February 26, 2025. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Ombretta Salvucci, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W264, Rockville, 

Maryland 20850, 240–276–7286, salvucco@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–3: 

SBIR Contract Review. 

Date: February 27, 2025. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W106, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Eduardo Emilio Chufan, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850, 240–276–7975, chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–6: NCI 

Clinical and Translational Cancer Research. 

Date: February 28, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W260, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Robert F. Gahl, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9606 Medical 

Center Drive, Room 7W260, Rockville, 

Maryland 20850, 240–276–7869, robert.gahl@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1: NCI 

Clinical and Translational Cancer Research. 

Date: March 6, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W108, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Prevention and Control Clinical Trials 

Planning. 

Date: March 6, 2025. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W608, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W608, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–9: 

SBIR Contract Review Meeting. 

Date: March 7, 2025. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W612, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Prashant Sharma, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W612, Rockville, 

Maryland 20850, 240–275–6351, 

prashant.sharma@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–13: 

NCI Clinical and Translational Cancer 

Research. 

Date: March 13, 2025. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W618, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: E. Tian, Ph.D., Scientific 

Review Officer, Research Program Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W618, Rockville, 

Maryland 20850, 240–276–6611, tiane@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–10: 

SBIR Contract Review Meeting. 

Date: March 14, 2025. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W238, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Rockville, Maryland 20850, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Metastasis 

Research Network (U01). 

Date: March 21, 2025. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove, 9609 Medical Center Drive, 

Room 7W120, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive Room 7W120, 

Rockville, Maryland 20850, 240–276–6457, 

mh101v@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 16, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–30326 Filed 12–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 


ddrumheller on DSK120RN23PROD with NOTICES1